المؤلفون: Richard Cathomas, Clemens B. Caspar, Beat Thürlimann, Karin Ribi, Veronika Blum, Philipp von Burg, Sandro Anchisi, Roger von Moos, Pierre Bohanes, Corinne Schär, Ursina Zürrer-Härdi, Thomas von Briel, Daniel Dietrich, Meinrad Mannhart, Michael Mark

المصدر: Journal of Bone Oncology, Vol 21, Iss, Pp-(2020)
Journal of Bone Oncology

مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, HRQoL, health-related quality of life, lcsh:Diseases of the musculoskeletal system, Bone disease, Cross-sectional study, Patterns of care, Skeletal-related event, lcsh:RC254-282, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, RANKL, receptor activator of nuclear factor kappa-B ligand, law, Internal medicine, medicine, RCT, randomized controlled trial, business.industry, Incidence (epidemiology), Bone metastases, Bone-targeting agents, IBCSG, International Breast Cancer Study Group, Bone metastasis, Non-interventional, SAKK, Swiss Group for Clinical Cancer Research, Symptomatic skeletal events, BP, bisphosphonate, medicine.disease, SGMO, Schweizerische Gesellschaft für Medizinische Onkologie, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, BTA, bone-targeted agent, Regimen, 030104 developmental biology, Denosumab, Oncology, 030220 oncology & carcinogenesis, SRE, symptomatic skeletal-related event, SSE, symptomatic skeletal event, lcsh:RC925-935, Risk assessment, business, mCRPC, metastatic castration-resistant prostate cancer, medicine.drug, Research Article

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::220b86e86723bb98399ca3c55fbf0103
https://pubmed.ncbi.nlm.nih.gov/31970055

المؤلفون: Mark M; Department of Hematology/Oncology, Kantonsspital Graubünden, Loestrasse 170, 7000 Chur, Switzerland., Thürlimann B; Kantonsspital St. Gallen, St. Gallen, Switzerland., Ribi K; International Breast Cancer Study Group IBCSG (IBCSG), Bern, Switzerland., Schär C; Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland., Dietrich D; Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center, Bern, Switzerland., Cathomas R; Department of Hematology/Oncology, Kantonsspital Graubünden, Loestrasse 170, 7000 Chur, Switzerland., Zürrer-Härdi U; Kantonsspital Winterthur, Winterthur, Switzerland., von Briel T; Klinik Hirslanden, Zürich, Switzerland., Anchisi S; Hôpital du Valais, Sion, Switzerland., Bohanes P; Centre de Chimiothérapie Anti-Cancéreuse, Lausanne, Switzerland., Blum V; Kantonsspital Luzern, Luzern, Switzerland., von Burg P; Burgerspital Solothurn, Solothurn, Switzerland., Mannhart M; Andreasklinik Cham Zug, Cham, Switzerland., Caspar CB; Kantonsspital Baden, Baden, Switzerland., von Moos R; Department of Hematology/Oncology, Kantonsspital Graubünden, Loestrasse 170, 7000 Chur, Switzerland.

المصدر: Journal of bone oncology [J Bone Oncol] 2019 Dec 16; Vol. 21, pp. 100273. Date of Electronic Publication: 2019 Dec 16 (Print Publication: 2020).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101610292 Publication Model: eCollection Cited Medium: Print ISSN: 2212-1366 (Print) Linking ISSN: 22121366 NLM ISO Abbreviation: J Bone Oncol Subsets: PubMed not MEDLINE